Orbimed Advisors - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q1 2023$9,468,750
+19.1%
12,500,000
-37.5%
0.19%
+22.4%
Q4 2022$7,950,000
-32.4%
20,000,0000.0%0.15%
-30.3%
Q3 2022$11,760,000
+30.7%
20,000,0000.0%0.22%
+33.7%
Q2 2022$9,000,000
-25.0%
20,000,0000.0%0.16%
-16.4%
Q1 2022$12,000,00020,000,0000.20%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 17,000,000$16,407,5504.62%
BRAIDWELL LP 114,338,000$109,764,4803.47%
Castle Creek Arbitrage, LLC 10,000,000$9,635,0002.27%
ARISTEIA CAPITAL, L.L.C. 67,223,000$64,534,0801.74%
Graham Capital Management, L.P. 55,529,000$53,481,7231.26%
683 Capital Management, LLC 14,750,000$14,186,5501.10%
TFG Asset Management GP Ltd 5,850,000$5,622,5001.02%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 21,875,000$21,039,3750.87%
ADVENT CAPITAL MANAGEMENT /DE/ 33,421,000$32,084,1600.75%
Context Capital Management, LLC 6,110$5,8580.47%
View complete list of BRIDGEBIO PHARMA INC shareholders